Medical Properties Trust (MPW) to Release Earnings on Thursday

Key Points

• Medical Properties Trust (MPW) is set to release its Q3 2025 earnings on October 30, 2025, with analysts predicting earnings of $0.16 per share and revenue of $244.89 million.
• The company has announced a quarterly dividend of $0.08 per share, offering an annualized yield of 6.2%, despite having a negative return on equity of 28.80%.
• As of the latest trading session, Medical Properties Trust's stock is valued at $5.19, with analysts maintaining a cautious outlook, reflected in several sell and hold ratings.

Medical Properties Trust (NYSE:MPW - Get Free Report) is expected to be announcing its Q3 2025 results before the market opens on Thursday, October 30th. Analysts expect the company to announce earnings of $0.16 per share and revenue of $244.8920 million for the quarter. Investors are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, October 30, 2025 at 11:00 AM ET.

Medical Properties Trust (NYSE:MPW - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The business had revenue of $240.36 million for the quarter, compared to analyst estimates of $231.90 million. Medical Properties Trust had a negative net margin of 155.20% and a negative return on equity of 28.80%. The firm's quarterly revenue was down 9.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.23 earnings per share. On average, analysts expect Medical Properties Trust to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Medical Properties Trust Stock Up 2.5%

NYSE:MPW traded up $0.13 during trading hours on Friday, hitting $5.19. 1,574,827 shares of the company's stock traded hands, compared to its average volume of 10,003,873. The firm has a market cap of $3.12 billion, a P/E ratio of -2.18 and a beta of 1.39. Medical Properties Trust has a twelve month low of $3.51 and a twelve month high of $6.34. The company has a debt-to-equity ratio of 2.00, a quick ratio of 2.76 and a current ratio of 2.76. The stock's fifty day moving average price is $4.85 and its two-hundred day moving average price is $4.72.

Medical Properties Trust Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, October 9th. Shareholders of record on Thursday, September 11th were given a $0.08 dividend. This represents a $0.32 annualized dividend and a yield of 6.2%. The ex-dividend date of this dividend was Thursday, September 11th. Medical Properties Trust's dividend payout ratio is presently -13.39%.

Institutional Trading of Medical Properties Trust

Large investors have recently made changes to their positions in the stock. BNP Paribas Financial Markets boosted its stake in shares of Medical Properties Trust by 94.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 65,348 shares of the real estate investment trust's stock worth $282,000 after acquiring an additional 31,758 shares in the last quarter. Boothbay Fund Management LLC boosted its stake in Medical Properties Trust by 132.2% during the 2nd quarter. Boothbay Fund Management LLC now owns 64,402 shares of the real estate investment trust's stock valued at $278,000 after purchasing an additional 264,402 shares during the period. WINTON GROUP Ltd bought a new stake in Medical Properties Trust during the 2nd quarter valued at approximately $265,000. United Services Automobile Association bought a new stake in Medical Properties Trust during the 1st quarter valued at approximately $240,000. Finally, Focus Partners Wealth boosted its stake in Medical Properties Trust by 11.7% during the 1st quarter. Focus Partners Wealth now owns 32,690 shares of the real estate investment trust's stock valued at $197,000 after purchasing an additional 3,415 shares during the period. Institutional investors own 71.79% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on MPW shares. Zacks Research raised Medical Properties Trust from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 20th. Royal Bank Of Canada dropped their target price on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating on the stock in a research report on Monday, June 30th. Wall Street Zen lowered Medical Properties Trust from a "hold" rating to a "sell" rating in a research report on Saturday, July 5th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Medical Properties Trust in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company dropped their target price on Medical Properties Trust from $5.00 to $4.50 and set an "underweight" rating on the stock in a research report on Wednesday, August 27th. One investment analyst has rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Reduce" and a consensus price target of $5.40.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.